Chewing gum containing phage associated lytic enzymes for treating streptococcal A infections
US6685937B2 · kind B2 · utility
6Cited by
94References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 25, 2001 |
| Grant date | Feb 3, 2004 |
| Priority date | — |
| Expiry date | May 25, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/15
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A chewing gum composition produced by mixing an effective amount of lysin enzyme produced by group C streptococcal bacteria infected with a C1 bacteriophage and a carrier for delivering said lysin enzyme to a mouth, throat, or nasal passage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.